These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8482572)

  • 21. Effect of rate control on speech production and intelligibility in dysarthria.
    Van Nuffelen G; De Bodt M; Vanderwegen J; Van de Heyning P; Wuyts F
    Folia Phoniatr Logop; 2010; 62(3):110-9. PubMed ID: 20424466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Be Clear: A New Intensive Speech Treatment for Adults With Nonprogressive Dysarthria.
    Park S; Theodoros D; Finch E; Cardell E
    Am J Speech Lang Pathol; 2016 Feb; 25(1):97-110. PubMed ID: 26882004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting Intelligibility Gains in Individuals With Dysarthria From Baseline Speech Features.
    Fletcher AR; McAuliffe MJ; Lansford KL; Sinex DG; Liss JM
    J Speech Lang Hear Res; 2017 Nov; 60(11):3043-3057. PubMed ID: 29075753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Voice in Friedreich Ataxia.
    Vogel AP; Wardrop MI; Folker JE; Synofzik M; Corben LA; Delatycki MB; Awan SN
    J Voice; 2017 Mar; 31(2):243.e9-243.e19. PubMed ID: 27501923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of familiarity on identifying prosodic vocalizations produced by children with severe dysarthria.
    Patel R; Schroeder B
    Clin Linguist Phon; 2007 Oct; 21(10):833-48. PubMed ID: 17882696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intelligibility and the acoustic characteristics of speech in amyotrophic lateral sclerosis (ALS).
    Mulligan M; Carpenter J; Riddel J; Delaney MK; Badger G; Krusinski P; Tandan R
    J Speech Hear Res; 1994 Jun; 37(3):496-503. PubMed ID: 8084181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The living with dysarthria group: implementation and feasibility of a group intervention for people with dysarthria following stroke and family members.
    Mackenzie C; Paton G; Kelly S; Brady M; Muir M
    Int J Lang Commun Disord; 2012; 47(6):709-24. PubMed ID: 23121529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting Intelligibility Gains in Dysarthria Through Automated Speech Feature Analysis.
    Fletcher AR; Wisler AA; McAuliffe MJ; Lansford KL; Liss JM
    J Speech Lang Hear Res; 2017 Nov; 60(11):3058-3068. PubMed ID: 29075755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of rate control on the intelligibility and naturalness of dysarthric speech.
    Yorkston KM; Hammen VL; Beukelman DR; Traynor CD
    J Speech Hear Disord; 1990 Aug; 55(3):550-60. PubMed ID: 2381196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intonation and speech rate in dysarthric speech.
    Le Dorze G; Ouellet L; Ryalls J
    J Commun Disord; 1994 Mar; 27(1):1-18. PubMed ID: 8006203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construct-related validity of the TOCS measures: comparison of intelligibility and speaking rate scores in children with and without speech disorders.
    Hodge MM; Gotzke CL
    J Commun Disord; 2014; 51():51-63. PubMed ID: 25069811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The curative effect of task-oriented approach in combination with articulation approach on spastic dysarthria].
    Zhu SJ; Qu Y; Liu K
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):779-82. PubMed ID: 24325111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intelligibility in acquired dysarthria--a neuro-phonetic approach: three case studies.
    Grunwell P; Huskins S
    J Commun Disord; 1979 Feb; 12(1):9-22. PubMed ID: 422750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Representation Learning Based Speech Assistive System for Persons With Dysarthria.
    Chandrakala S; Rajeswari N
    IEEE Trans Neural Syst Rehabil Eng; 2017 Sep; 25(9):1510-1517. PubMed ID: 27992342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of Palatal Lift Prosthesis on Dysarthric Speech.
    Alfwaress FS; Bibars AR; Hamasha A; Maaitah EA
    J Craniofac Surg; 2017 Jan; 28(1):30-35. PubMed ID: 27831974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing Vowel Centralization in Dysarthria: A Comparison of Methods.
    Fletcher AR; McAuliffe MJ; Lansford KL; Liss JM
    J Speech Lang Hear Res; 2017 Feb; 60(2):341-354. PubMed ID: 28124069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Speech treatment improves dysarthria in multisystemic ataxia: a rater-blinded, controlled pilot-study in ARSACS.
    Vogel AP; Stoll LH; Oettinger A; Rommel N; Kraus EM; Timmann D; Scott D; Atay C; Storey E; Schöls L; Synofzik M
    J Neurol; 2019 May; 266(5):1260-1266. PubMed ID: 30840144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ISi-Speech: A Digital Training System for Acquired Dysarthria.
    Frieg H; Muehlhaus J; Ritterfeld U; Bilda K
    Stud Health Technol Inform; 2017; 242():330-334. PubMed ID: 28873818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterizing intonation deficit in motor speech disorders: an autosegmental-metrical analysis of spontaneous speech in hypokinetic dysarthria, ataxic dysarthria, and foreign accent syndrome.
    Lowit A; Kuschmann A
    J Speech Lang Hear Res; 2012 Oct; 55(5):1472-84. PubMed ID: 23033442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment.
    D'Alatri L; Paludetti G; Contarino MF; Galla S; Marchese MR; Bentivoglio AR
    J Voice; 2008 May; 22(3):365-72. PubMed ID: 17368837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.